Opendata, web and dolomites

VEMoS SIGNED

Virtual eye model system for personalised refractive surgery treatment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 VEMoS project word cloud

Explore the words cloud of the VEMoS project. It provides you a very rough idea of what is the project "VEMoS" about.

tomographer    educational    groups    aging    clinics    clients    2010    customer    auh    population    vulnerable    workers    patented    simulations    global    28    impacts    measurable    standardise    innovation    neural    ophthalmic    virtual    revolutionise    2022    mature    ophthalmology    worldwide    hardware    model    elderly    plan    outcomes    cso    drivers    innovative    revolutionary    independent    social    uncorrected    commercialisation    surgery    driving    58    deficits    topographer    refractive    rates    simulation    responsible    incidence    time    decision    skills    employments    predicted    vision    quantified    health    vissum    39    241bn    profit    treatments    patient    50    progress    hours    impairments    accumulated    life    2050    personalised    tech    death    reduce    almost    2026    145    diagnostic    software    myopia    combining    medicine    generating    children    front    action    satisfaction    productivity    2m    ms    equal    reported    37m    aberrometer    economic    vemos    create    risk    icpermed    revenue    3m    manufacturing    quality    ec    clinical    eye    chuc    spent    screens    companies    post    provides    successful    network    full   

Project "VEMoS" data sheet

The following table provides information about the project.

Coordinator
VALCASADO SA 

Organization address
address: EBANISTAS 4
city: ALCORCON
postcode: 28923
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙935˙335 €
 EC max contribution 2˙997˙269 € (76%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2022-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VALCASADO SA ES (ALCORCON) coordinator 1˙426˙919.00
2    COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL IT (BADIA A SETTIMO) participant 761˙902.00
3    AARHUS UNIVERSITETSHOSPITAL DK (AARHUS) participant 406˙371.00
4    CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA E.P.E. PT (COIMBRA) participant 402˙076.00

Map

 Project objective

The incidence of myopia is predicted to rise from 28% of the global population in 2010 to almost 50% in 2050. Factors such as population aging and increase of hours spent in front of screens are driving the increase in global eye deficits. Vision impairments reduce the quality of life, affect economic and educational opportunities and increase the risk of death. This is particularly important for vulnerable groups such as elderly, children, workers and drivers. Overall, WHO reported that uncorrected vision was responsible for €241bn of productivity loss per year worldwide. Our innovative Virtual Eye Model System (VEMoS) is based on patented revolutionary ophthalmic diagnostic devices (CSO’s MS-39 tomographer/topographer and the unique open-field aberrometer), as well as on innovative simulation software developed by Vissum. Overall, our innovation provides personalised clinical-decision support based on each patient’s eye measurements and neural network simulations of post-surgery outcomes, improving surgery success and patient satisfaction rates. By combining CSO’s ophthalmic high-tech hardware design, manufacturing and commercialisation skills with Vissum’s refractive surgery and software development and independent clinical testing by CHUC and AUH, this project is expected to bring economic, social and health impacts, including progress towards achieving the EC action plan on personalised medicine “ICPerMed”. Our goal is to mature, scale-up and demonstrate the production of the VEMoS system, targeting ophthalmology clinics as clients, and with the aim to standardise refractive surgery decision making and revolutionise the refractive surgery field with personalised treatments. A successful VEMoS project will allow us to create measurable impacts on our companies, quantified as accumulated revenue of €145.3m in five years (2022-2026), equal to accumulated operating profit of €58.2m, creating 60 full time employments, and generating €37m in reduced customer costs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VEMOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VEMOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

Bio-LP-1 (2020)

A novel rapid environmental test for the human pathogen Legionella

Read More  

PAV-DT (2019)

A disruptive technology that enables low cost real-time monitoring of road pavement condition by any ordinary vehicle circulating on the road, and automatically designs plans for predictive maintenance.

Read More  

SAMBAfun (2018)

System for AcceleroMeter-Based Assessment of cardiac FUNction

Read More